Literature DB >> 1278094

The influence of cholinergic, adrenergic, and serotonergic drugs on the afternoon surge of plasma prolactin in ovariectomized, estrogen-treated rats.

M G Subramanian, R R Gala.   

Abstract

The effects of systemic administration of cholinergic, adrenergic, and serotonergic drugs on the afternoon surge of plasma prolactin was investigated using ovariectomized, polyestradiol phosphate (PEP)-injected rats bearing aortic catheters. Basal prolactin levels were elevated and similar after PEP administration for a period of 5 weeks, and an afternoon surge in plasma prolactin persisted for a period of 3 weeks before the magnitude of the surge diminished. The plasma estradiol levels were significantly higher for the 1100 and 1300 h samples than for the 1500 and 1700 h samples. Cornified vaginal epithelia were predominant in the vaginal smears of all animals throughout the 49-day experimental period. The cholinergic agonists arecoline, nicotine, and carbachol significantly inhibited the afternoon surge of prolactin. The muscarinic antagonist atropine resulted in a partial inhibition of the surge while the nicotinic antagonist mecamylamine did not have any inhibitory effect. The alpha-adrenergic blockers phenoxybenzamine and phentolamine and the beta-blocker propranolol inhibited the prolactin surge, with phenoxybenzamine being most effective. The administration of the serotonergic antagonist methysergide resulted in only a partial blockade of the afternoon prolactin surge. The data suggest that both the adrenergic and serotonergic systems may have a positive input in the afternoon surge of plasma prolactin. It appears that the cholinergic system does not play a significant role in the afternoon surge.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1278094     DOI: 10.1210/endo-98-4-842

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  The influence of long term estrogen treatment on plasma prolactin levels induced by ether anesthesia in ovariectomized rats.

Authors:  G T Goodman; D M Lawson
Journal:  Experientia       Date:  1977-04-15

2.  Augmentation of prolactin response to TRH after cyproheptadine.

Authors:  A C Ammini; R J Dash; R Sialy
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

3.  The lack of an effect of cholinergic agonists on anterior pituitary prolactin production in vitro.

Authors:  M D Campbell; S Jaques; R R Gala
Journal:  Experientia       Date:  1978-11-15

4.  Effect of estrogen administration on the induction of the plasma prolactin afternoon surge and on anterior pituitary prolactin concentration extracted at different pHs.

Authors:  R R Gala; N Sensui; D M Lawson
Journal:  Experientia       Date:  1983-02-15

5.  Gonadotropin, prolactin and TSH secretion in patients with myasthenia gravis.

Authors:  M S Shapiro; E Weiss; E Kott; R Taragan; L Shenkman
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

Review 6.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

7.  Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.

Authors:  C M Kuhn; R A Vogel; R B Mailman; R A Mueller; S M Schanberg; G R Breese
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Inhibition by cholinergic agonists of the prolactin release induced by morphine.

Authors:  T Muraki; Y Tokunaga; T Nakadate; R Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

9.  Alteration by prolactin of surface charge and membrane fluidity of rat 13762 mammary ascites tumor cells.

Authors:  D A Zarkower; L D Plank; E Kunze; A Keith; P Todd; W C Hymer
Journal:  Cell Biophys       Date:  1984-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.